Skip to main content
Clinical Trials/ISRCTN60158641
ISRCTN60158641CompletedNot Applicable

Embryo development of fresh versus vitrified metaphase II after intracytoplasmic sperm injection (ICSI): a prospective randomised active-controlled parallel group sibling-oocyte study

G.EN.E.R.A. - Clinica Valle Giulia (Italy)0 sites40 target enrollmentStarted: May 29, 2009Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • Between September 2008 and February 2009 consecutive patients not older than 42 years of age, presenting greater than 6 normal appearing metaphase II (MII) oocytes and undergoing ICSI treatment with ejaculated sperm in the Centre for Reproductive Medicine GENERA in Rome.

Exclusion Criteria

  • 1. Female partner older than 42 years old
  • 2. Less than 6 normal appearing MII oocytes retrieved
  • 3. Surgically extracted spermatozoa
  • 4. Very severe oligoastenoteratozoospermia (motile sperm count less than 500,000/ml after preparation)
  • 5. Patients enrolled in our polar body biopsy programme

Investigators

Sponsor
G.EN.E.R.A. - Clinica Valle Giulia (Italy)

Similar Trials